Corneal Blindness

Limbal stem cell deficiency (LSCD) is a painful eye disease that prevents the cornea renewing itself and can result in reduced vision or blindness, ocular irritation and visual glare. Current treatments for LSCD include standard corneal transplantation as well as limbal tissue grafting. However, both treatments have severe limitations in terms of success rates, the risk of tissue rejection and shortage of tissue supply, and can lead to the damage of donors’ healthy eyes.

The aim of this trial is to apply ex vivo limbal stem cells to address limbal stem cell deficiency (LSCD) to see if they can halt or repair damage to the eye.

Principal Investigator:
Prof. Bal Dhillon, Eye Pavilion and Royal Infirmary, Edinburgh

OTHER PROJECTS

See how else UKSCF is helping stem cell research.

Read More
 OTHER PROJECTS

SUPPORT US

Your donations and fundraising help to advance the most promising research projects that have the greatest potential to deliver patient benefits.

Read more
SUPPORT US